Coulter Partners secures Dieter Weinand as Board Chair for AstriVax Therapeutics
LONDON, UK, and BOSTON, MA, September 2, 2025 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully completed a search assignment for AstriVax Therapeutics NV and is pleased to announce the placement of Dieter Weinand as Chair of its Board of Directors.
